Work

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis: Results of a phase III multicenter, double‐blind, placebo‐controlled trial

Year: 1995

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.45.7.1268

Authors: K. P. Johnson, B. R. Brooks, J. A. Cohen, C. C. Ford, J. Goldstein, R. P. Lisak, L. W. Myers, H. S. Panitch, J. W. Rose, R. B. Schiffer, T. Vollmer, L. P. Weiner, J. S. Wolinsky, Copolymer 1 Multiple Sclerosis Study Group

Institutions: University of Maryland, Baltimore, University of Wisconsin–Madison, University of New Mexico, Wayne State University, Yale University, University of Pennsylvania

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Food and Drug Administration

Award: G7323893935

OpenAlex ID: W2005506388

FWCI: 32.38

Cites:

Cited by: 1,912

Related to: 10